Yasuaki Okuda

Successful use of a humanized anti–interleukin‐6 receptor antibody, tocilizumab, to treat amyloid A amyloidosis complicating juvenile idiopathic arthritis

Yasuaki Okuda, Kiyoshi Takasugi · Arthritis & Rheumatism · 2006 · 150 citations

Life Sciences, Clinical Sciences, Pharmacotherapy +15

Comparison of the clinical utility of tocilizumab and anti-TNF therapy in AA amyloidosis complicating rheumatic diseases

Yasuaki Okuda, Makoto Ohnishi, Kenichiro Matoba et al. · Modern Rheumatology · 2013 · 72 citations

Life Sciences, Immunology, Pharmacotherapy +16

Review of tocilizumab in the treatment of rheumatoid arthritis

Yasuaki Okuda · Biologics · 2008 · 64 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Successful tocilizumab treatment in a patient with adult-onset Still’s disease complicated by chronic active hepatitis B and amyloid A amyloidosis

Dai Kishida, Yasuaki Okuda, Makoto Onishi et al. · Modern Rheumatology · 2010 · 64 citations

Medicine, Internal Medicine, Pharmacotherapy +14

Postischemic Intraventricular Administration of FGF-2 Expressing Adenoviral Vectors Improves Neurologic Outcome and Reduces Infarct Volume after Transient Focal Cerebral Ischemia in Rats

Takuji Watanabe, Yasuaki Okuda, Naosuke Nonoguchi et al. · Journal of Cerebral Blood Flow & Metabolism · 2004 · 61 citations

Medicine, Neuroscience, Pharmacology +17